Lini Imaji Kreasi Ekosistem Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Lini Imaji Kreasi Ekosistem Tbk. trades at Rp226 (market cap 1.49T, 28.32M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Lini Imaji Kreasi Ekosistem Tbk. is far larger — about 2.5× UBC Medical Indonesia Tbk.'s market cap, and Lini Imaji Kreasi Ekosistem Tbk. is more actively traded (28.32M versus 817.3K). Which is the better fit depends on your goals.
| FUTR | LABS | |
|---|---|---|
Market Cap | 1.49T | 584.6B |
Volume | 28.32M | 817.3K |
Lot | 283.22K | 8.17K |
Turnover | 6.41B | 120.01M |
Average Price | 226.29 | 146.84 |
Value | 6.41B | 120.01M |
Indicative Equilibrium Price | 226 | 146 |
Indicative Equilibrium Volume | 4.51K | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lini Imaji Kreasi Ekosistem Tbk (the “Company”) was established under the name of PT LinikiniAspirasi Kreasi based on Notarial Deed No. 74 of Janty Lega, S.H., M.Kn., dated July 29, 2021. The Company started its commercial operations in 2021. The immediate and ultimate parent entities of the Company are PT Digital Futurama Global and PT Investasi Gemilang Maju, respectively.
Read more on FUTR →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →